Fumaric Acid

Fumaric Acid

SCHEMBL8710922

CCOC(=O)Nc1ccc(C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc2OC)cc1.O=C(O)C=CC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 2/20 0.44
MEN1 known ✓ O00255 1/20 0.44
HTR1A known ✓ P08908 1/20 0.41
ADRA1A known ✓ P35348 1/20 0.41
HTR2A known ✓ P28223 1/20 0.41
CYP2C19 P33261 3/20 0.47
CYP2D6 P10635 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.44
UBE2N P61088 1/20 0.44
HSD17B10 Q99714 1/20 0.43
HTT P42858 1/20 0.43
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 2/20 0.42
GAA P10253 1/20 0.42
BLM P54132 1/20 0.41
CYP3A4 P08684 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HSD11B1 P28845 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8714316 1.00 CYP2C19 (0.47) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
SCHEMBL8710662 0.96 CYP2C19 (0.51) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8715698 0.90 CYP2C19 (0.49) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8715696 0.90 CYP2C19 (0.49) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8712380 0.89 CYP2D6 (0.49) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8710800 0.89 CYP2D6 (0.47) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8712378 0.89 CYP2D6 (0.49) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8710804 0.89 CYP2D6 (0.47) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8711116 0.89 CYP2C19 (0.46) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1
Fumaric Acid SCHEMBL8711119 0.89 CYP2C19 (0.46) CYP2C19CYP2D6SMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5728835-A HYPOTENSIVE AGENTS; ANTIISCHEMIC AGENTS TOA EIYO, LTD. (JP) 1998-03-17 US disclosed
EP-0661266-A1 Substituted cyclic amine compounds as 5HT2 antagonists TOA EIYO LTD. (JP) 1995-07-05 EP disclosed